Related Experiment Video
Updated: Jun 2, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Micro-RNA expression in cisplatin resistant germ cell tumor cell lines
Matthias Port1, Stephanie Glaesener, Christian Ruf
1Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. matthias.port@web.de
Background:
We compared microRNA expression patterns in three cisplatin resistant sublines derived from paternal cisplatin sensitive germ cell tumor cell lines in order to improve our understanding of the mechanisms of cisplatin resistance.
Methods:
Three cisplatin resistant sublines (NTERA-2-R, NCCIT-R, 2102EP-R) showing 2.7-11.3-fold increase in drug resistance after intermittent exposure to increasing doses of cisplatin were compared to their parental counterparts, three well established relatively cisplatin sensitive germ cell tumor cell lines (NTERA-2, NCCIT, 2102EP). Cells were cultured and total RNA was isolated from all 6 cell lines in three independent experiments. RNA was converted into cDNA and quantitative RT-PCR was run using 384 well low density arrays covering almost all (738) known microRNA species of human origin.
Results:
Altogether 72 of 738 (9.8%) microRNAs appeared differentially expressed between sensitive and resistant cell line pairs (NTERA-2R/NTERA-2 = 43, NCCIT-R/NCCIT = 53, 2102EP-R/2102EP = 15) of which 46.7-95.3% were up-regulated (NTERA-2R/NTERA-2 = 95.3%, NCCIT-R/NCCIT = 62.3%, 2102EP-R/2102EP = 46.7%). The number of genes showing differential expression in more than one of the cell line pairs was 34 between NTERA-2R/NTERA-2 (79%) and NCCIT-R/NCCIT (64%), and 3 and 4, respectively, between these two cell lines and 2102EP-R/2102EP (about 27%). Only the has-miR-10b involved in breast cancer invasion and metastasis and has-miR-512-3p appeared to be up-regulated (2-3-fold) in all three cell lines. The hsa-miR-371-373 cluster (counteracting cellular senescence and linked with differentiation potency), as well as hsa-miR-520c/-520h (inhibiting the tumor suppressor p21) were 3.9-16.3 fold up-regulated in two of the three cisplatin resistant cell lines. Several new micro-RNA species missing an annotation towards cisplatin resistance could be identified. These were hsa-miR-512-3p/-515/-517/-518/-525 (up to 8.1-fold up-regulated) and hsa-miR-99a/-100/-145 (up to 10-fold down-regulated).
Conclusion:
Examining almost all known human micro-RNA species confirmed the miR-371-373 cluster as a promising target for explaining cisplatin resistance, potentially by counteracting wild-type P53 induced senescence or linking it with the potency to differentiate. Moreover, we describe for the first time an association of the up-regulation of micro-RNA species such as hsa-miR-512-3p/-515/-517/-518/-525 and down-regulation of hsa-miR-99a/-100/-145 with a cisplatin resistant phenotype in human germ cell tumors. Further functional analyses are warranted to gain insight into their role in drug resistance.
Insights
This study identified key microRNAs (miRNAs) associated with cisplatin resistance in germ cell tumors. Upregulated miRNAs like miR-371-373 and miR-512-3p, and downregulated miRNAs such as miR-99a, offer new targets for overcoming drug resistance.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Investigated microRNA (miRNA) expression patterns in cisplatin-resistant germ cell tumor (GCT) cell lines.
- Aimed to elucidate mechanisms underlying cisplatin resistance in GCTs.
Purpose of the Study:
- To compare miRNA expression profiles between cisplatin-sensitive and resistant GCT cell lines.
- To identify specific miRNAs involved in conferring cisplatin resistance.
Main Methods:
- Utilized three cisplatin-resistant GCT sublines and their sensitive parental counterparts.
- Isolated total RNA and performed quantitative reverse transcription-polymerase chain reaction (qRT-PCR) using low-density arrays covering 738 human miRNAs.
Main Results:
- Identified 72 differentially expressed miRNAs (9.8%) between sensitive and resistant cell lines, with most showing upregulation.
- The miR-371-373 cluster and miR-520c/-520h were upregulated in resistant lines, potentially counteracting senescence and promoting differentiation.
- New potential markers for cisplatin resistance, including upregulated hsa-miR-512-3p/-515/-517/-518/-525 and downregulated hsa-miR-99a/-100/-145, were identified.
Conclusions:
- The miR-371-373 cluster is a promising target for understanding and potentially overcoming cisplatin resistance in GCTs.
- Established a novel association between specific miRNA alterations (upregulation of hsa-miR-512-3p family, downregulation of hsa-miR-99a family) and cisplatin resistance.
- Further functional studies are recommended to explore the role of these miRNAs in drug resistance mechanisms.
Related Concept Videos
MicroRNAs
MicroRNAs
